Will herd immunity curb COVID-19? Not with rampant spread of ‘anti-science, anti-authority, anti-vaccine’ views

unnamed

With government support, three coronavirus vaccines are expected to be studied in large-scale clinical trials in the next three months.

“The best we’ve ever done is measles, which is 97 to 98 percent effective,” said [Anthony] Fauci, the director of the National Institute of Allergy and Infectious Diseases. “That would be wonderful if we get there. I don’t think we will. I would settle for [a] 70, 75% effective vaccine.”

CNN poll last month found one-third of Americans said they would not try to get vaccinated against Covid, even if the vaccine is widely available and low cost.

In an interview [June 16], CNN asked Fauci whether a vaccine with 70% to 75% efficacy taken by only two-thirds of the population would provide herd immunity to the coronavirus.

ADVERTISEMENT

“No — unlikely,” he answered.

Related article:  Coronavirus may survive longer than expected on uncleaned surfaces

Herd immunity is when a sufficient proportion of a population is immune to an infectious disease, either through prior illness or vaccination, so that spread from person to person unlikely.

Fauci noted that “there is a general anti-science, anti-authority, anti-vaccine feeling among some people in this country — an alarmingly large percentage of people, relatively speaking.”

He said given the power of the anti-vaccine movement, “we have a lot of work to do” to educate people on the truth about vaccines.

ADVERTISEMENT
ADVERTISEMENT

“It’s not going to be easy,” he said. “Anyone [who] thinks it will be easy is not facing reality.”

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend